Jean Paul Galmiche

Summary

Country: France

Publications

  1. ncbi French consensus conference on hepatitis C: screening and treatment
    J P Galmiche
    Hotel Dieu, CHU de Nantes, France
    Gut 42:892-8. 1998
  2. ncbi Endoluminal therapies for gastro-oesophageal reflux disease
    Jean Paul Galmiche
    Department of Gastroenterology and Hepatology, CIC INSERM, CHU Nantes, 44093, Nantes, France
    Lancet 361:1119-21. 2003
  3. ncbi Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Antagonist
    J P Galmiche
    Department of Gastroenterology and Hepatology, , 44093 Nantes Cedex, France
    Gut 51:472-4. 2002
  4. ncbi Endoscopic treatment of gastroesophageal reflux disease--fact or fancy?
    Jean Paul Galmiche
    Department of Gastroenterology and Hepatology, CHU Nantes, 44093 Nantes, France
    Curr Gastroenterol Rep 4:177-8. 2002
  5. ncbi Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole
    J P Galmiche
    Centre Hospitalier Universitaire de Nantes, Nantes Cedex, France
    Aliment Pharmacol Ther 15:1343-50. 2001
  6. ncbi Endoscopy-negative reflux disease
    J P Galmiche
    Department of Gastroenterology and Hepatology and INSERM U 539, Hotel Dieu, CHU Nantes, 44093 Nantes Cedex, France
    Curr Gastroenterol Rep 3:206-14. 2001
  7. ncbi Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half-life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers
    J P Galmiche
    CIC INSERM, CHU de Nantes, Nantes, France
    Aliment Pharmacol Ther 19:655-62. 2004
  8. ncbi On-demand treatment of gastro-oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo
    J P Galmiche
    Department of Gastroenterology and Hepatology, University of Nantes, France
    Aliment Pharmacol Ther 12:909-17. 1998
  9. ncbi How do we offer clinical relief to patients with gastro-oesophageal reflux disease?
    J P Galmiche
    Hopital Hotel Dieu, Service Hepato gastro enterologie, Nantes, France
    Eur J Gastroenterol Hepatol 12:S3-6. 2000
  10. ncbi Enteric glia protect against Shigella flexneri invasion in intestinal epithelial cells: a role for S-nitrosoglutathione
    Mathurin Flamant
    INSERM U913, Place Alexis Ricordeau, Nantes Cedex, France
    Gut 60:473-84. 2011

Collaborators

Detail Information

Publications46

  1. ncbi French consensus conference on hepatitis C: screening and treatment
    J P Galmiche
    Hotel Dieu, CHU de Nantes, France
    Gut 42:892-8. 1998
    ..gut 1998;:892-898)..
  2. ncbi Endoluminal therapies for gastro-oesophageal reflux disease
    Jean Paul Galmiche
    Department of Gastroenterology and Hepatology, CIC INSERM, CHU Nantes, 44093, Nantes, France
    Lancet 361:1119-21. 2003
    ..Comparative studies of the cost-effectiveness of endoscopic therapy should also include medical strategies such as intermittent or on-demand PPI therapy...
  3. ncbi Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Antagonist
    J P Galmiche
    Department of Gastroenterology and Hepatology, , 44093 Nantes Cedex, France
    Gut 51:472-4. 2002
  4. ncbi Endoscopic treatment of gastroesophageal reflux disease--fact or fancy?
    Jean Paul Galmiche
    Department of Gastroenterology and Hepatology, CHU Nantes, 44093 Nantes, France
    Curr Gastroenterol Rep 4:177-8. 2002
  5. ncbi Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole
    J P Galmiche
    Centre Hospitalier Universitaire de Nantes, Nantes Cedex, France
    Aliment Pharmacol Ther 15:1343-50. 2001
    ..Rabeprazole has been shown to be more potent and faster than other proton pump inhibitors in in vitro studies and highly effective in decreasing oesophageal acid exposure in patients with gastro-oesophageal reflux disease (GERD)...
  6. ncbi Endoscopy-negative reflux disease
    J P Galmiche
    Department of Gastroenterology and Hepatology and INSERM U 539, Hotel Dieu, CHU Nantes, 44093 Nantes Cedex, France
    Curr Gastroenterol Rep 3:206-14. 2001
    ..Antireflux surgery may be indicated in carefully selected patients. In the future, pharmacologic approaches targeted to transient lower esophageal sphincter relaxation or visceral perception should be developed...
  7. ncbi Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half-life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers
    J P Galmiche
    CIC INSERM, CHU de Nantes, Nantes, France
    Aliment Pharmacol Ther 19:655-62. 2004
    ..Aim : To compare the effects of tenatoprazole 20 mg (T20), tenatoprazole 40 mg (T40) and esomeprazole 40 mg (E40) on intragastric acidity in healthy volunteers...
  8. ncbi On-demand treatment of gastro-oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo
    J P Galmiche
    Department of Gastroenterology and Hepatology, University of Nantes, France
    Aliment Pharmacol Ther 12:909-17. 1998
    ..To compare the effects of ranitidine 75 mg with those of either cimetidine 200 mg or placebo given on demand for relief of typical symptoms of gastro-oesophageal reflux disease during a 15-day period...
  9. ncbi How do we offer clinical relief to patients with gastro-oesophageal reflux disease?
    J P Galmiche
    Hopital Hotel Dieu, Service Hepato gastro enterologie, Nantes, France
    Eur J Gastroenterol Hepatol 12:S3-6. 2000
    ..In conclusion, with modern PPIs like lansoprazole, rapid and full resolution of symptoms is now achievable in the large majority of patients...
  10. ncbi Enteric glia protect against Shigella flexneri invasion in intestinal epithelial cells: a role for S-nitrosoglutathione
    Mathurin Flamant
    INSERM U913, Place Alexis Ricordeau, Nantes Cedex, France
    Gut 60:473-84. 2011
    ..EGC-derived S-nitrosoglutathione (GSNO) has been shown to regulate IEB permeability. Whether EGCs and GSNO protect the IEB during infectious insult by pathogens such as Shigella flexneri is not known...
  11. ncbi Functional mapping of NPY/PYY receptors in rat and human gastro-intestinal tract
    Laurent Ferrier
    Centre de Recherche en Nutrition Humaine, INSERM U539, CHU Hotel Dieu, 44093 Nantes, France
    Peptides 23:1765-71. 2002
    ....
  12. ncbi Rho kinase blockade prevents inflammation via nuclear factor kappa B inhibition: evidence in Crohn's disease and experimental colitis
    Jean Pierre Segain
    INSERM U 539, Department of Gastroenterology, and Centre d Investigation Clinique, Centre Hospitalier Universitaire, Hotel Dieu, Nantes, France
    Gastroenterology 124:1180-7. 2003
    ..Data from in vitro studies suggest that RhoA could be involved in the inflammatory response. We investigated the role of RhoA and its downstream effector Rho kinase in intestinal inflammation...
  13. ncbi Epidemiology of the complications of gastroesophageal reflux disease
    Kafia Belhocine
    Institut des Maladies de l Appareil Digestif Nantes, Universite de Nantes, Nantes, France
    Dig Dis 27:7-13. 2009
    ..Barrett's esophagus is the most prevalent complication of GERD and seems to be associated with an increased mortality rate. However, cancer incidence is low and most patients die from other causes, especially cardiovascular disease...
  14. ncbi Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial
    Jean Paul Galmiche
    Department of Gastroenterology and Hepatology, Nantes University, CIC INSERM, Place Alexis Ricordeau, 44093 Nantes, France
    JAMA 305:1969-77. 2011
    ..Gastroesophageal reflux disease (GERD) is a chronic, relapsing disease with symptoms that have negative effects on daily life. Two treatment options are long-term medication or surgery...
  15. ncbi Degraded carrageenan causing colitis in rats induces TNF secretion and ICAM-1 upregulation in monocytes through NF-kappaB activation
    Claudine Benard
    INRA, UMR 1280 PHAN, Universite de Nantes, CHU Hotel Dieu, Nantes, France
    PLoS ONE 5:e8666. 2010
    ..All these effects were linked to NF-kappaB activation. These data strongly suggest that the degraded forms of CGN have a pronounced effect on monocytes, characteristic of an inflammatory phenotype...
  16. ncbi Treatment of gastroesophageal reflux disease in adults: an individualized approach
    Jean Paul Galmiche
    Department of Gastroenterology and Hepatology, CIC Inserm CHU, Nantes, France
    Dig Dis 22:148-60. 2004
    ..The potential efficacy of new drugs, especially the GABA(B) agonists and the fast onset acid suppressors, as well as the cost-effectiveness of non-drug strategies (surgery and endoluminal therapies) should be further evaluated...
  17. ncbi Medical therapy of gastroesophageal reflux disease
    Emmanuel Coron
    Department of Gastroenterology and Hepatology, University Hospital, Nantes, France
    Curr Opin Gastroenterol 23:434-9. 2007
    ..Despite their increasing use, up to 40% of patients are not fully satisfied with their antireflux therapy. Recent data on efficacy and safety are reviewed and causes of failure are discussed...
  18. ncbi Screening for esophagitis and Barrett's esophagus with wireless esophageal capsule endoscopy: a multicenter prospective trial in patients with reflux symptoms
    Jean Paul Galmiche
    CHU Nantes, Nantes, France
    Am J Gastroenterol 103:538-45. 2008
    ..Esophageal capsule endoscopy (ECE) is a new technology that allows noninvasive investigation of the esophagus. Our aim was to evaluate prospectively the diagnostic yield of ECE in patients with chronic reflux symptoms...
  19. ncbi Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence
    Céline Deleau
    Institut des Maladies de l Appareil Digestif CIC INSERM et Service d Hépato Gastroentérologie, CHU de Nantes, Nantes Saint Herblain, France
    Eur J Gastroenterol Hepatol 23:275-81. 2011
    ..Our aim was to evaluate diagnostic performances of (18)F-fluorodeoxyglucose-positron emission tomography ((18)F-FDG-PET)/computed tomography (CT) as compared with CT in the detection of CRC recurrence...
  20. ncbi Interleukin-15 and its soluble receptor mediate the response to infliximab in patients with Crohn's disease
    Gregory Bouchaud
    INSERM, U892, Equipe Cytokine Récepteur, Nantes, France
    Gastroenterology 138:2378-87. 2010
    ..We investigated serum levels and cellular expression of interleukin (IL)-15 and its receptor (sIL-15Ralpha) in patients with Crohn's disease (CD) treated with infliximab; and the effect on sIL-15Ralpha secretion by epithelial cells...
  21. ncbi Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs?
    Stanislas Bruley Des Varannes
    Institut des Maladies de L appareil Digestif, Centre Hospitalier Universitaire, Nantes, France
    Best Pract Res Clin Gastroenterol 24:905-21. 2010
    ..How a better pharmacological profile may translate into clinical benefit should now be tested in appropriate, controlled studies...
  22. ncbi Effects of tablet and effervescent formulations of ranitidine 75 mg and cimetidine 200 mg on gastric acidity and oesophageal acid exposure in healthy humans
    S Bruley des Varannes
    Department of Gastroenterology and Hepatology, College of Medicine, University of Nantes, France
    Aliment Pharmacol Ther 12:1155-61. 1998
    ..Because of their tolerance and safety, low doses of H2-receptor antagonists are now increasingly used in some countries for self-care medication of gastro-oesophageal reflux symptoms...
  23. ncbi Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding
    J Gournay
    Service d Hepato gastro enterologie, Hotel Dieu, Centre Hospitalier Universitaire de Nantes, France
    Hepatology 31:1239-45. 2000
    ..However no beneficial effects were observed on other parameters reflecting the efficacy of treatment...
  24. ncbi Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo)
    S Bruley des Varannes
    Institut des Maladies de L appareil Digestif, CHU Hotel Dieu, Nantes, France
    Gut 54:1682-6. 2005
    ..Recently, a telemetric catheter free system (CFS) (Bravo; Medtronic) was developed. The aim of this study was to determine the concordance of data between the conventional pH measurement system (CPHMS) and the CFS Bravo...
  25. ncbi Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms
    Thibaud Lebouvier
    UMR 913, INSERM, Nantes, France
    PLoS ONE 5:e12728. 2010
    ....
  26. ncbi Acidity induces c-Fos expression in a subpopulation of human colonic submucosal neurons
    Emmanuelle Tixier
    Institut National de la Santé et de la Recherche Médicale U539, Hopital Hotel Dieu, Nantes, France
    Neurosci Lett 404:23-7. 2006
    ..In conclusion, our results demonstrate that acidic mucosal challenge induced the activation of a population of human submucosal neurons with a specific neurochemical coding...
  27. ncbi GORD and functional disorders of upper gut
    Jean Paul Galmiche
    Department of Gastroenterology and Hepatology, CIC INSERM, CHU, Nantes, France
    Eur J Gastroenterol Hepatol 16:819-21. 2004
  28. ncbi Antireflux surgery for non-erosive and erosive reflux disease in community practice
    R Thibault
    Department of Gastroenterology, Hepatology and Nutritional Support, Institut des Maladies de l'Appareil Digestif, University Hospital, Nantes, France
    Aliment Pharmacol Ther 24:621-32. 2006
    ..Nearly one-third of the non-erosive reflux disease patients continue to take proton-pump inhibitors. These results highlight the need for careful selection of patients before antireflux surgery...
  29. ncbi Enteric glial cells protect neurons from oxidative stress in part via reduced glutathione
    Hind Abdo
    INSERM U913 1, Place Alexis Ricordeau, 44093 Nantes, France
    FASEB J 24:1082-94. 2010
    ..Abdo, H., Derkinderen, P., Gomes, P., Chevalier, J., Aubert, P., Masson, D., Galmiche, J.-P., Vanden Berghe, P., Neunlist, M., Lardeux, B. Enteric glial cells protect neurons from oxidative stress in part via reduced glutathione...
  30. ncbi Adaptation to low-protein diet increases inhibition of gastric emptying by CCK
    Veronique Leray
    Centre de Recherche en Nutrition Humaine, INSERM U539, Hotel Dieu, 44093 Nantes, France
    Peptides 24:1929-34. 2003
    ..Our data suggest that modulation of gastric emptying after adaptation to a low-protein diet involves up-regulation of both CCK-A receptors and CCK-induced contraction of antral smooth muscle...
  31. ncbi Review article: respiratory manifestations of gastro-oesophageal reflux disease
    J P Galmiche
    CHU Nantes, Service Hépato gastroentérologie, Institut des Maladies de l Appareil Digestif and Institut National de Santé et de Recherche Médicale, Nantes, France
    Aliment Pharmacol Ther 27:449-64. 2008
    ..Respiratory manifestations represent one of the most prevalent and difficult-to-manage extra-oesophageal syndromes of gastro-oesophageal reflux disease...
  32. ncbi Early diagnosis of esophageal adenocarcinoma
    Bruno Buecher
    CIC Inserm and Department of Gastroenterology, and Hepatology, , Nantes Cedex, France
    Semin Gastrointest Dis 14:136-45. 2003
    ..Although promising, none of these techniques is currently recommendable for routine surveillance of patients with Barrett's esophagus. Further evaluation is warranted to define the optimal method and standardize the procedures...
  33. ncbi Non-erosive reflux disease and atypical gastro-oesophageal reflux disease manifestations: treatment results
    Jean Paul Galmiche
    Department of Gastroenterology and Hepatology, CIC Inserm CHU, Nantes University, France
    Drugs 66:7-13; discussion 29-33. 2006
    ..This article reviews the treatment results and outlines approaches to the evaluation, diagnosis and therapy of NERD and atypical GERD manifestations...
  34. ncbi Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease
    Thierry Piche
    , Nantes, France
    Gastroenterology 124:894-902. 2003
    ..Although different mechanisms are likely to be involved, excess release of GLP-1 may account, at least in part, for these effects...
  35. ncbi Impedance-pH monitoring in proton pump inhibitor resistant patients: ready for clinical application?
    J P Galmiche
    Institut des Maladies de l'Appareil Digestif, , 44093 Nantes, France
    Gut 55:1379-81. 2006
  36. ncbi Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective case-control study with cost analysis
    J Gournay
    Service de Gastroentérologie et d Hépatologie, Centre Hospitalier Universitaire de Nantes, Nantes, France
    Aliment Pharmacol Ther 16:1529-38. 2002
    ..Percutaneous ethanol injection and hepatic resection are the most widely used curative therapeutic options for patients with compensated liver disease and small hepatocellular carcinoma...
  37. ncbi Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators
    T Piche
    INSERM U913, Nantes, France
    Gut 58:196-201. 2009
    ..We aimed to investigate (1) paracellular permeability in colonic biopsies of patients with IBS; and (2) the ability of soluble factors from colonic biopsies to reproduce these alterations in vitro...
  38. ncbi Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn's disease: a prospective study
    A Bourreille
    Institut de Maladies de l'Appareil Digestif, University Hospital, Nantes, France
    Gut 55:978-83. 2006
    ..Additional follow up studies are needed to assess the clinical relevance of such lesions. At the present time, it seems that WCE cannot systematically replace ileocolonoscopy in the regular management of patients after surgery...
  39. ncbi Neurochemical coding of myenteric neurones in the human gastric fundus
    S Pimont
    INSERM U 539, Place Alexis Ricordeau, Nantes, France CIC INSERM, Place Alexis Ricordeau, Nantes, France
    Neurogastroenterol Motil 15:655-62. 2003
    ..The precise functional role of the neurochemically identified classes of neurones remains to be determined...
  40. ncbi H. pylori and transient lower esophageal sphincter relaxations induced by gastric distension in healthy humans
    F Zerbib
    , Human Nutrition Research Center, and Department of Gastroenterology and Hepatology, University of Nantes, 44035 Nantes, France
    Am J Physiol Gastrointest Liver Physiol 281:G350-6. 2001
    ..These results suggest that H. pylori-associated inflammation does not affect the motor events involved in the pathogenesis of gastroesophageal reflux...
  41. ncbi Interleukin-8 increases acetylcholine response of rat intestinal segments
    V Plattner
    Human Nutrition Research Center, INSERM U 539, , Nantes, France
    Aliment Pharmacol Ther 15:1227-32. 2001
    ..CONCLUSION: In vitro, IL-8 increases contractile response of the ileum to ACh in a dose-dependent manner. This effect is not neurally mediated, but seems to involve protein synthesis by intestinal mucosa...
  42. ncbi Proinflammatory role of leptin in experimental colitis in rats benefit of cholecystokinin-B antagonist and beta3-agonist
    M Barbier
    Centre de Recherche en Nutrition Humaine, , CHU Hotel Dieu, et INRA, Nantes, France
    Life Sci 69:567-80. 2001
    ..Further studies are required to determine if these results have clinical significance...
  43. ncbi Changes in chemical coding of myenteric neurones in ulcerative colitis
    M Neunlist
    INSERM U 539, Place Alexis Ricordeau, Nantes, France
    Gut 52:84-90. 2003
    ..0%). CONCLUSION: Remodelling of myenteric neurones in UC involves a shift from mainly cholinergic to more SP positive innervation. This effect may constitute part of the neuronal basis for the motility disturbances observed in UC...
  44. ncbi Pharmacological targets in gastro-oesophageal reflux disease
    Thierry Piche
    Hepatogastroenterology, CHU Nice, France
    Basic Clin Pharmacol Toxicol 97:333-41. 2005
    ..Lastly, further research is necessary to better understand the complex mechanisms involved in oesophageal sensitivity and mucosal defence...
  45. ncbi Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting
    Stanislas Bruley des Varannes
    Institut des Maladies de l'Appareil Digestif, CIC-INSERM-CHU - NANTES, France
    World J Gastroenterol 12:2569-73. 2006
    ..CONCLUSION: The poor specificity of the proton-pump inhibitor (PPI) test does not support such an approach to establish a diagnosis of GERD in a primary care setting...
  46. ncbi Effects of bronchial obstruction on lower esophageal sphincter motility and gastroesophageal reflux in patients with asthma
    Frank Zerbib
    Service d Hepato Gastroenterologie, Hôpital Saint André, Bordeaux
    Am J Respir Crit Care Med 166:1206-11. 2002
    ..These results support the belief that, in asthma, bronchial obstruction may be responsible for reflux or may aggravate reflux through a mechanism that remains to be further clarified...